DxCheck Launches AI-Powered DxPro Clinical Workspace
DxCheck says DxPro combines cited clinical answers, daily updates and patient insights for clinicians.
Related stories
Dynamix to Liquidate After Failing to Complete Business Combination
Dynamix Corp. said it could not complete a business combination by its deadline and will liquidate. It expects to redeem public shares for about $10.71 each; Thursday is expected t
L impact | EQUITY | Oct 29, 2026, 06:05 PM UTC
Analysts Raise Price Targets for Axogen After Q3 Results
Truist and Barclays lifted Axogen price targets to $60, from $53 and $50, respectively; Wells Fargo raised its target to $56 from $48. Truist and Barclays maintained Buy ratings.
M impact | EQUITY | Oct 29, 2026, 06:03 PM UTC
Darling Ingredients Reports Q3 2026 Adjusted EBITDA of $514 Million
Darling Ingredients reported Q3 2026 net income of $267 million, reduced net debt by $420 million during the period and reaffirmed full-year 2026 EBITDA guidance of $2.2 billion to
M impact | EQUITY | Oct 29, 2026, 06:03 PM UTC
Bunge Reports Third-Quarter 2026 Revenue of $23.8 Billion, EPS
Bunge reported GAAP diluted EPS of $1.64, versus $0.86 a year earlier, and adjusted EPS of $2.56, versus $2.27. It reiterated full-year adjusted EPS guidance of $9.25 to $9.75.
M impact | EQUITY | Oct 29, 2026, 06:03 PM UTC
Alnylam Q3 Revenue Reaches $1.46 Billion; Reaffirms 2026 Guidance
Q3 revenue exceeded FactSet consensus of $1.43 billion, with adjusted earnings of $16.26 per share. Product sales rose 59% year over year to $1.15 billion; the company cited slower
M impact | EQUITY | Oct 29, 2026, 06:03 PM UTC
Instacart Reports Q3 2026 Revenue of $1.095 Billion, Up 17%
Instacart reported GTV of $10.528 billion, up 15% year over year, and GAAP net income of $147 million, up 2%. Advertising and other revenue rose 23% to $331 million. Following the
M impact | EQUITY | Oct 29, 2026, 06:03 PM UTC